Epigenetics of autism spectrum disorder: Histone deacetylases

CEJ Tseng, CJ McDougle, JM Hooker, NR Zürcher - Biological psychiatry, 2022 - Elsevier
The etiology of autism spectrum disorder (ASD) remains unknown, but gene-environment
interactions, mediated through epigenetic mechanisms, are thought to be a key contributing …

Structure, mechanism, and inhibition of the zinc-dependent histone deacetylases

NJ Porter, DW Christianson - Current opinion in structural biology, 2019 - Elsevier
Zinc-dependent histone deacetylases (HDACs) regulate the biological function of histone
and non-histone proteins through the hydrolysis of acetyllysine side chains to yield free …

Intrinsic structural dynamics dictate enzymatic activity and inhibition

VK Shukla, L Siemons… - Proceedings of the …, 2023 - National Acad Sciences
Enzymes are known to sample various conformations, many of which are critical for their
biological function. However, structural characterizations of enzymes predominantly focus …

Cryo-EM structure of the Saccharomyces cerevisiae Rpd3L histone deacetylase complex

AB Patel, J Qing, KH Tam, S Zaman, M Luiso… - Nature …, 2023 - nature.com
The Rpd3L histone deacetylase (HDAC) complex is an ancient 12-subunit complex
conserved in a broad range of eukaryotes that performs localized deacetylation at or near …

Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities

DA Rodrigues, PSM Pinheiro… - Medicinal research …, 2020 - Wiley Online Library
Despite the applicability of histone deacetylase inhibitors (HDACis) for cancer treatment,
several works in the literature have shown that these inhibitors can be used in several other …

Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases

A Chakrabarti, J Melesina, FR Kolbinger… - Future medicinal …, 2016 - Taylor & Francis
Histone deacetylase 8 (HDAC8), a unique class I zinc-dependent HDAC, is an emerging
target in cancer and other diseases. Its substrate repertoire extends beyond histones to …

Cannabinoid receptor subtype 2 (CB2R) in a multitarget approach: perspective of an innovative strategy in cancer and neurodegeneration

GF Mangiatordi, F Intranuovo, P Delre… - Journal of Medicinal …, 2020 - ACS Publications
The cannabinoid receptor subtype 2 (CB2R) represents an interesting and new therapeutic
target for its involvement in the first steps of neurodegeneration as well as in cancer onset …

[HTML][HTML] Utilization of AlphaFold models for drug discovery: Feasibility and challenges. Histone deacetylase 11 as a case study

F Baselious, D Robaa, W Sippl - Computers in Biology and Medicine, 2023 - Elsevier
Abstract Histone deacetylase 11 (HDAC11), an enzyme that cleaves acyl groups from
acylated lysine residues, is the sole member of class IV of HDAC family with no reported …

Innovative strategies for selective inhibition of histone deacetylases

AR Maolanon, AS Madsen, CA Olsen - Cell chemical biology, 2016 - cell.com
Histone deacetylases (HDAC) are a family of closely related enzymes involved in epigenetic
and posttranscriptional regulation of numerous genes and proteins. Their deregulation is …

Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD

Y Mesrouze, F Bokhovchuk, M Meyerhofer, P Fontana… - Elife, 2017 - elifesciences.org
TEAD (TEA/ATTS d omain) transcription factors are the most distal effectors of the Hippo
pathway. YAP (Y es-a ssociated p rotein) is a coactivator protein which, upon binding to …